The Asia Pacific Radiotherapy Market would witness market growth of 6.7% CAGR during the forecast period (2022-2028).
External beam radiation is administered to patients five days a week as an outpatient for a specific amount of time. In most cases, treatments are spaced out over a few weeks to give the healthy cells time to recuperate in-between sessions of radiation therapy. Radiation can be particularly harmful to some malignancies. In these situations, radiation may be administered alone to cause cancer to lessen or disappear entirely. Chemotherapy or even other anti-cancer medications may be administered initially in some situations. Radiation may be used for different malignancies either before surgery to reduce the tumor or after surgery to prevent cancer from returning.
Radiation therapy may be the recommended treatment for some malignancies that can be treated either through surgery or radiation therapy. This is due to the fact that radiation may cause less harm and that the affected body part may function more normally after therapy. Radiation, chemotherapy, or other anti-cancer medications may be combined with various cancer types. Radiation is made more effective by radio sensitizers, which increase the sensitivity of cancer cells to radiation. When administered jointly, radiation and anti-cancer medications can help each other operate even more effectively than if they were delivered separately in treating some types of cancer.
With a blend of several cultures, religions, festivals, languages, and ethnic groupings, India is a place of diversity. More than 1.38 billion people call the nation home as of 2020, making up 17.7% of the world's population with a density of 464 people per square kilometer. More than half of Indians are under the age of 25, while the average age is 28.4 years. In terms of nominal gross domestic product (GDP), India is the fifth-largest economy in the world, but it is third in terms of purchasing power parity.
The China market dominated the Asia Pacific Radiotherapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $754.9 million by 2028. The Japan market is estimated a CAGR of 6.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.3% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Clinics and Others. Based on Type, the market is segmented into External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Radiotherapy Market is Projected to reach USD 9.3 Billion by 2028, at a CAGR of 41.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Siemens Healthineers AG, Accuray, Incorporated, Elekta AB, Eckert & Ziegler AG, Ion Beam Applications SA, iCAD Inc., Isoray Inc., Mevion Medical Systems, Inc., and Nordion Inc. (Sotera Health LLC).
By End User
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
